PGP and cancer: In the context of cancer or autoimmune disease, studies have demonstrated that drug efflux transporters such as P-gp and MRP1 could participate in the secretion of proinflammatory cytokines following activation of T-cells (Drach et al., 1996; Pawlik et al., 2005; Zhang et al., 2006).